|
Post by mnholdem on Jun 2, 2017 10:50:43 GMT -5
Outcome Health is the ad firm that MannKind is currently utilizing to advertise Afrezza in clinic waiting rooms and doctors' offices.
Meet the 31-Year Old Worth $3 Billion Helping Drug Companies Like Bristol-Myers Squibb (BMY) and Pfizer (PFE) Market in Doctors' Offices
Excerpt:
On one level, Outcome falls clearly into what pharmaceutical companies refer to as “point of care” marketing. That traditionally meant the brochures and handouts found in doctors’ offices. But Outcome explodes the concept, although one might question the desire of people to be constantly bombarded with video content, infomercials and advertisements everywhere they go, including their doctor’s waiting rooms.
Shah argues that it’s more than point-of-care marketing, and the company is generating revenue across the balance sheet—from direct-to-consumer marketing, from general marketing, from R&D aspects because of tie-ins to clinical trial information. He’s also working on approaches for healthcare providers and with Medicare on new payment models.
“We’ve created a multi-sided network that gives payers and life science companies a seat at the table,” Shah told Forbes. “They can help doctors and patients make the best decision every time.”
Outcome Health claims its tablets or screens are in 40,000 doctor’s offices, or about 20 percent. It has about 100 content partners. Doctors can pay for the screens, but 99 percent of them don’t, opting for an advertisement-supported version.
By 2020, Shah has the ambitious goal of working with 70 percent of all healthcare providers.
Link: www.biospace.com/News/meet-the-31-year-old-worth-3-billion-helping-drug/458211/source=TopBreaking
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jun 6, 2017 10:08:24 GMT -5
|
|
|
Post by od on Oct 14, 2017 11:23:30 GMT -5
WSJ: Healthcare unicorn misled advertisers
medcitynews.com/2017/10/wsj-article-asserts-healthcare-unicorn-used-misleading-advertising-data/
|
|